Monika Cserjan-Puschmann
Overview
Explore the profile of Monika Cserjan-Puschmann including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
383
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hanaee-Ahvaz H, Baumann M, Tauer C, Albrecht B, Wiltschi B, Cserjan-Puschmann M, et al.
Sci Rep
. 2024 Oct;
14(1):25375.
PMID: 39455661
Protein engineering with non-canonical amino acids (ncAAs) holds great promises for diverse applications, however, there are still limitations in the implementation of this technology at manufacturing scale. The know-how to...
2.
Fohler L, Leibetseder L, Cserjan-Puschmann M, Striedner G
Microb Cell Fact
. 2024 Oct;
23(1):272.
PMID: 39390547
Background: The global plastic waste crisis requires combined recycling strategies. One approach, enzymatic degradation of PET waste into monomers, followed by re-polymerization, offers a circular economy solution. However, challenges remain...
3.
Herdina A, Bozdogan A, Aspermair P, Dostalek J, Klausberger M, Lingg N, et al.
Biosens Bioelectron
. 2024 Sep;
267:116807.
PMID: 39341071
This study presents a graphene field-effect transistor (gFET) biosensor with dual detection capabilities for SARS-CoV-2: one RNA detection assay to confirm viral positivity and the other for nucleocapsid (N-)protein detection...
4.
Liu J, Fischer A, Cserjan-Puschmann M, Lingg N, Oostenbrink C
J Chem Inf Model
. 2024 Jul;
64(14):5691-5700.
PMID: 38946265
The Caspase-based fusion protein technology (CASPON) allows for universal cleavage of fusion tags from proteins of interest to reconstitute the native N-terminus. While the CASPON enzyme has been optimized to...
5.
Muller M, Gibisch M, Brocard C, Cserjan-Puschmann M, Striedner G, Hahn R
Protein Expr Purif
. 2024 Jun;
222:106537.
PMID: 38944221
Peptides are used for diagnostics, therapeutics, and as antimicrobial agents. Most peptides are produced by chemical synthesis, but recombinant production has recently become an attractive alternative due to the advantages...
6.
Gibisch M, Muller M, Tauer C, Albrecht B, Hahn R, Cserjan-Puschmann M, et al.
Microb Cell Fact
. 2024 Jun;
23(1):166.
PMID: 38840157
Background: Recombinant peptide production in Escherichia coli provides a sustainable alternative to environmentally harmful and size-limited chemical synthesis. However, in-vivo production of disulfide-bonded peptides at high yields remains challenging, due...
7.
Koppl C, Buchinger W, Striedner G, Cserjan-Puschmann M
Microb Cell Fact
. 2024 Mar;
23(1):86.
PMID: 38509572
Background: Escherichia coli is one of the most commonly used host organisms for the production of biopharmaceuticals, as it allows for cost-efficient and fast recombinant protein expression. However, challenging proteins...
8.
Jurjevec A, Brocard C, Striedner G, Cserjan-Puschmann M, Toca-Herrera J, Hahn R
J Biotechnol
. 2024 Feb;
384:29-37.
PMID: 38423471
Cell disintegration and protein extraction are crucial steps in downstream process development for biopharmaceuticals produced in E. coli. In this study, we explored the extraction mechanism of polyethyleneimine (PEI) at...
9.
Vazulka S, Schiavinato M, Tauer C, Wagenknecht M, Cserjan-Puschmann M, Striedner G
Microb Cell Fact
. 2024 Jan;
23(1):14.
PMID: 38183013
Background: Escherichia coli is a cost-effective expression system for production of antibody fragments like Fabs. Various yield improvement strategies have been applied, however, Fabs remain challenging to produce. This study...
10.
Hanaee-Ahvaz H, Cserjan-Puschmann M, Mayer F, Tauer C, Albrecht B, Furtmuller P, et al.
Heliyon
. 2023 Dec;
9(12):e22463.
PMID: 38046162
Functionalization of proteins by incorporating reactive non-canonical amino acids (ncAAs) has been widely applied for numerous biological and therapeutic applications. The requirement not to lose the intrinsic properties of these...